BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM
51 results:

  • 1. HPV prevalence and distribution characteristics in postmenopausal women from Nanjing, China.
    Yin X; Zhang C; Wu X; Feng J; Xie J; Li Y
    BMC Womens Health; 2024 Jan; 24(1):68. PubMed ID: 38267981
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The impact of age-relevant and generic infographics on knowledge, attitudes and intention to attend cervical screening: A randomized controlled trial.
    Waite F; Marlow LAV; Nemec M; Waller J
    Br J Health Psychol; 2024 Feb; 29(1):204-220. PubMed ID: 37770383
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Are "additional cuts" effective for positive margins in cervical conization? It varies according to the doctor.
    Sun Y; He Y; Zhuoma M; Hua Z; Sun Z; Jiang N; Kong F; Xiao Z
    World J Surg Oncol; 2023 Aug; 21(1):260. PubMed ID: 37612769
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The digital expression profile of BMP7, CDKN2C, HIST1H3G, and PKMYT1 genes improves high-grade cervical lesion detection in liquid-based cytology.
    Causin RL; Sussuchi da Silva L; Leal LF; Possati-Resende JC; Evangelista AF; Matsushita GM; Scapulatempo-Neto C; Tavares Guerreiro Fregnani JH; Antônio de Oliveira M; Musselwhite LW; Chiquitelli Marques MM; Reis RM
    Cancer Cytopathol; 2023 Jul; 131(7):454-464. PubMed ID: 37069588
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. EMPOWER cervical-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer.
    Oaknin A; Monk BJ; Vergote I; Cristina de Melo A; Kim YM; Lisyanskaya AS; Samouëlian V; Kim HS; Gotovkin EA; Damian F; Chang CL; Takahashi S; Li J; Mathias M; Fury MG; Ivanescu C; Reaney M; LaFontaine PR; Lowy I; Harnett J; Chen CI; Tewari KS
    Eur J Cancer; 2022 Oct; 174():299-309. PubMed ID: 35922251
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Preoperative serum creatinine as an independent prognostic biomarker in patients with early-stage cervical adenocarcinoma].
    Li N; Chen RZ; Wang FF; Li BH
    Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(26):1993-1998. PubMed ID: 35817723
    [No Abstract]    [Full Text] [Related]  

  • 7. A comparison of high-grade cervical abnormality risks in women living with and without human immunodeficiency virus undergoing routine cervical-cancer screening.
    Castle PE; Befano B; Schiffman M; Wentzensen N; Lorey T; Poitras N; Hyer M; Cheung LC
    Prev Med; 2022 Sep; 162():107157. PubMed ID: 35810936
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Survival with Cemiplimab in Recurrent cervical cancer.
    Tewari KS; Monk BJ; Vergote I; Miller A; de Melo AC; Kim HS; Kim YM; Lisyanskaya A; Samouëlian V; Lorusso D; Damian F; Chang CL; Gotovkin EA; Takahashi S; Ramone D; Pikiel J; Maćkowiak-Matejczyk B; Guerra Alía EM; Colombo N; Makarova Y; Rischin D; Lheureux S; Hasegawa K; Fujiwara K; Li J; Jamil S; Jankovic V; Chen CI; Seebach F; Weinreich DM; Yancopoulos GD; Lowy I; Mathias M; Fury MG; Oaknin A;
    N Engl J Med; 2022 Feb; 386(6):544-555. PubMed ID: 35139273
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Analysis of related factors for cervical intraepithelial neoplasia Ⅱ
    Mao YN; You ZX
    Zhonghua Fu Chan Ke Za Zhi; 2021 Oct; 56(10):691-696. PubMed ID: 34823318
    [No Abstract]    [Full Text] [Related]  

  • 10. Translation and validation of the Chinese version of the MD Anderson symptom inventory for measuring perioperative symptom burden in patients with gynecologic cancer.
    Zhang T; Zheng YY; Yang ZR; Shi Q; Wang XS; Zhao J; Yang M; Wu CL; Wang GR
    BMC Womens Health; 2021 Jul; 21(1):276. PubMed ID: 34325677
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical Impact of Pelvic Lymph Node Status in Locally Advanced cervical cancer Patients Treated by Concurrent Chemoradiation Therapy.
    Katanyoo K; Thavaramara T
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):491-497. PubMed ID: 33639665
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Estimating the impact of increasing cervical cancer screening in the National Breast and cervical cancer Early Detection Program among low-income women in the USA.
    Pollack LM; Ekwueme DU; Hung MC; Miller JW; Chang SH
    Cancer Causes Control; 2020 Jul; 31(7):691-702. PubMed ID: 32436037
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical comparison of two human papillomavirus detection assays: GenoFlow and reverse line blot.
    Alhamlan FS; Khayat HH; Obeid DA; Tulba AM; Baduwais TS; Alfageeh MB; Al-Ahdal MN
    J Infect Dev Ctries; 2020 Jan; 14(1):97-103. PubMed ID: 32088690
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prevalence and genotype distribution of human papillomavirus in Zhengzhou, China, in 2016.
    Liu J; Ma S; Qin C; Zheng S; Chen Z; Huang Y; Xiong J; Huo Y
    Arch Virol; 2020 Mar; 165(3):731-736. PubMed ID: 31907615
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA.
    Ye B; Shi J; Kang H; Oyebamiji O; Hill D; Yu H; Ness S; Ye F; Ping J; He J; Edwards J; Zhao YY; Guo Y
    RNA Biol; 2020 Nov; 17(11):1666-1673. PubMed ID: 31607216
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Low-Risk Human Papillomavirus Types in cervical Intraepithelial Neoplasia 2-3 and in Invasive cervical cancer Patients.
    Siegler E; Reichman Y; Kugelman N; Mackuli L; Lavie O; Ostrovsky L; Shaked-Mishan P; Segev Y
    J Low Genit Tract Dis; 2019 Oct; 23(4):248-252. PubMed ID: 31592971
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Serum SCCA levels in patients suffering cancers or other diseases.
    Yang D; Wang J; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():165-175. PubMed ID: 30905447
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. cancer incidence in Cotonou (Benin), 2014-2016: First results from the cancer Registry of Cotonou.
    Egue M; Gnangnon FHR; Akele-Akpo MT; Maxwell Parkin D
    Cancer Epidemiol; 2019 Apr; 59():46-50. PubMed ID: 30685574
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Preserved miR-361-3p Expression Is an Independent Prognostic Indicator of Favorable Survival in cervical cancer.
    Liu S; Song L; Yao H; Zhang L; Xu D; Li Q; Li Y
    Dis Markers; 2018; 2018():8949606. PubMed ID: 30344797
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Transperitoneal
    Prodromidou A; Machairas N; Spartalis E; Kostakis ID; Iavazzo C; Moris D; Tsilimigras DI; Athanasiou A; Nikiteas N
    Anticancer Res; 2018 Aug; 38(8):4677-4681. PubMed ID: 30061235
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.